IberiaBank’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$695K Sell
2,642
-32
-1% -$8.54K 0.08% 139
2020
Q1
$607K Buy
2,674
+1,478
+124% +$403K 0.08% 137
2019
Q4
$361K Sell
1,196
-7
-0.6% -$1.93K 0.04% 187
2019
Q3
$289K Sell
1,203
-3
-0.2% -$822 0.03% 195
2019
Q2
$340K Sell
1,206
-22
-2% -$6.01K 0.04% 194
2019
Q1
$352K Buy
+1,228
New +$355K 0.04% 191

Other funds holding ELV

IberiaBank's ELV Position: Q2 2020 in Review

IberiaBank reduced its Elevance Health (ELV) stake by 1.2% in Q2 2020, selling an estimated $8.54K and leaving 2,642 shares worth $695K. The position accounts for 0.08% of the portfolio, ranked #139.

IberiaBank first reported a position in ELV in Q1 2019 and has held it in 6 quarters since. 1,107 funds tracked by Wall St. Rank hold ELV as of Q2 2020.

  • IberiaBank held 2,642 shares of Elevance Health worth $695K as of Q2 2020.
  • IberiaBank sold 32 Elevance Health shares in Q2 2020, an estimated $8.54K.
  • Elevance Health made up 0.08% of IberiaBank's portfolio in Q2 2020, its #139 holding.
  • IberiaBank first reported a position in Elevance Health in Q1 2019 and has held it in 6 quarters since.
  • 1,107 funds tracked by Wall St. Rank held Elevance Health as of Q2 2020.

Based on IberiaBank's 13F filing for Q2 2020, filed 29 Jul 2020.